Chemify

Investor: Scottish Enterprise, UK Government (DBT)

Glasgow-headquartered digital chemistry pioneer Chemify has secured £22 million in strategic public growth funding to anchor an £89.9 million facility and technology expansion program, creating up to 300 highly skilled deep-tech jobs in Scotland. Summary of transaction details: Value: £22 million in public growth grants (£16 million from Scottish Enterprise and £6 million from the UK Government’s Department for Business, Innovation, Science and Trade), with Chemify contributing £67.9 million to complete the £89.9 million expansion program. Sector: DeepTech & AI / Life Sciences / Digital Chemistry & Robotics. Advisor: Not disclosed. Key Entities: Target: Chemify (Chemify Limited); Public Grant Partners: Scottish Enterprise, UK Government (Department for Business, Innovation, Science and Trade); Key Executive: Professor Lee Cronin (Founder & CEO). Location: Glasgow, Scotland, UK (Establishing Global HQ and R&D Hub at the Health Innovation Hub in Govan, Glasgow Riverside Innovation District). Note: Founded in 2019 as a spinout from the University of Glasgow by pioneering chemist Professor Lee Cronin, Chemify is developing the foundational infrastructure for automated chemistry, termed Chemputation. While traditional drug discovery and advanced material design rely heavily on manual synthesis and trial-and-error laboratory experimentation, Chemify combines digital AI models with physical robotics to programmatically design, synthesize, and test complex chemical molecules at scale. Through its automated manufacturing infrastructure—known as Chemifarms—and its Chemify Genesis software system, the company turns chemical code directly into physical compounds, drastically accelerating timelines and lowering development costs for pharmaceutical and advanced materials partners. This £89.9 million project will scale Chemify's Scottish workforce from 152 to over 450 employees, safeguard 100 existing roles, expand its automated manufacturing capacity, and establish its global headquarters at the University of Glasgow's Health Innovation Hub in Govan, positioning Chemify as the world's first "Chemistry Hyperscaler."

Investor: Rockspring, BlueYard, EOS VC Fund, Insight Partners, Triatomic Capital, Wing Venture Capital, 8VC

Investor: EOS Ventures, UK Government Innovation Accelerators program, Rocketship Ventures, Possible Ventures, Alix Ventures, Horizon Ventures, Blueyard Capital, Triatomic Capital